Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Arishya Sharma & Alexandru Almasan. (2018) Autophagy as a mechanism of Apo2L/TRAIL resistance. Cancer Biology & Therapy 19:9, pages 755-762.
Read now
Read now
Filiz Senbabaoglu, Ahmet Cingoz, Ezgi Kaya, Selena Kazancioglu, Nathan A. Lack, Ceyda Acilan & Tugba Bagci-Onder. (2016) Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme. Cancer Biology & Therapy 17:5, pages 546-557.
Read now
Read now
Articles from other publishers (79)
Yuqing Ren, Ruizhi Wang, Siyuan Weng, Hui Xu, Yuyuan Zhang, Shuang Chen, Shutong Liu, Yuhao Ba, Zhaokai Zhou, Peng Luo, Quan Cheng, Qin Dang, Zaoqu Liu & Xinwei Han. (2023) Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis. Molecular Cancer 22:1.
Crossref
Crossref
Xinyi Wang, Gonghuan Tang, Hui Guo, Jingjing Ma, Dongmei Liu, Yuwei Wang, Ruyi Jin, Zhi Li & Yuping Tang. (2023) Research Progress on the Anti-Tumor Mechanism and Reversal of Multidrug Resistance of Zuojin Pill and its Main Components, Evodiamine and Berberine. Natural Product Communications 18:3, pages 1934578X2311614.
Crossref
Crossref
Xupu Wang, Lizheng Wang, Wenmo Liu, Xinyao Feng, Hui Wu, Haihong Zhang, Jiaxin Wu, Wei Kong, Xianghui Yu & Bin Yu. (2022)
Production of Soluble Murine TRAILs in
Escherichia coli
with Zn
2+
Supplementation
. Protein & Peptide Letters 29:12, pages 1072-1081.
Crossref
Crossref
Nikita Thapa, Yong Chwae, Kwang Yoo, Tae-Bin Won, Daewook Kang, Daae Choi & Jaeyoung Kim. (2022) Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review). International Journal of Molecular Medicine 51:1.
Crossref
Crossref
Jinhao Jia, Jie Li, Qiusheng Zheng & Defang Li. (2022) A research update on the antitumor effects of active components of Chinese medicine ChanSu. Frontiers in Oncology 12.
Crossref
Crossref
Fu Peng, Minru Liao, Rui Qin, Shiou Zhu, Cheng Peng, Leilei Fu, Yi Chen & Bo Han. (2022) Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Feida Li, Xiaoyan Wang, Ming Wu, Jianhua Guan, Yuzhi Liang, Xiaolong Liu, Xinyi Lin & Jingfeng Liu. (2022) Biosynthetic cell membrane vesicles to enhance TRAIL-mediated apoptosis driven by photo-triggered oxidative stress. Biomaterials Science 10:13, pages 3547-3558.
Crossref
Crossref
Antonella Montinaro, Itziar Areso Zubiaur, Julia Saggau, Anna-Laura Kretz, Rute M. M. Ferreira, Omar Hassan, Ella Kitzig, Ines Müller, Mona A. El-Bahrawy, Silvia von Karstedt, Dagmar Kulms, Gianmaria Liccardi, Johannes Lemke & Henning Walczak. (2021) Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers. Cell Death & Differentiation 29:3, pages 492-503.
Crossref
Crossref
Tiziana Annese, Roberto Tamma & Domenico Ribatti. 2022. Handbook of Stem Cell Therapy. Handbook of Stem Cell Therapy
1389
1419
.
Tiziana Annese, Roberto Tamma & Domenico Ribatti. 2022. Handbook of Stem Cell Therapy. Handbook of Stem Cell Therapy
1
31
.
Ali Parsania, Mohammad Hassan Pouriayevali, Masoud Parsania & Mahdi Ghorbani. (2021) Chelidonium majus L. alkaloid extract enhances TRAIL-induced apoptosis in HeLa cell line through death receptors 4 and 5 upregulation. Gene Reports 25, pages 101311.
Crossref
Crossref
Jeong Uk Choi, Ji-young Kim, Seung Woo Chung, Na Kyeong Lee, Jooho Park, Seho Kweon, Young Seok Cho, Ha Rin Kim, Sung Mook Lim, Jin Woo Park, Kang Choon Lee & Youngro Byun. (2021) Dual mechanistic TRAIL nanocarrier based on PEGylated heparin taurocholate and protamine which exerts both pro-apoptotic and anti-angiogenic effects. Journal of Controlled Release 336, pages 181-191.
Crossref
Crossref
Ezgi Ozyerli-Goknar & Tugba Bagci-Onder. (2021) Epigenetic Deregulation of Apoptosis in Cancers. Cancers 13:13, pages 3210.
Crossref
Crossref
Elena A. Filippova, Marina V. Fridman, Alexey M. Burdennyy, Vitaly I. Loginov, Irina V. Pronina, Svetlana S. Lukina, Alexey A. Dmitriev & Eleonora A. Braga. (2021) Long Noncoding RNA GAS5 in Breast Cancer: Epigenetic Mechanisms and Biological Functions. International Journal of Molecular Sciences 22:13, pages 6810.
Crossref
Crossref
You-Take Oh & Shi-Yong Sun. (2021) Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling. Biomolecules 11:4, pages 499.
Crossref
Crossref
A.L. Heck, S. Mishra, T. Prenzel, L. Feulner, E. Achhammer, V. Särchen, B.S.J. Blagg, W. Schneider-Brachert, S. Schütze & J. Fritsch. (2021) Selective HSP90β inhibition results in TNF and TRAIL mediated HIF1α degradation. Immunobiology 226:2, pages 152070.
Crossref
Crossref
Izabela Kostova, Ranadip Mandal, Sven Becker & Klaus Strebhardt. (2020) The role of caspase-8 in the tumor microenvironment of ovarian cancer. Cancer and Metastasis Reviews 40:1, pages 303-318.
Crossref
Crossref
Tatsuya Hattori, Yoshinori Takahashi, Longgui Chen, Zhenyuan Tang, Carson A. Wills, Xinwen Liang & Hong-Gang Wang. (2020) Targeting the ESCRT-III component CHMP2A for noncanonical Caspase-8 activation on autophagosomal membranes. Cell Death & Differentiation 28:2, pages 657-670.
Crossref
Crossref
Asma Vafadar, Zahra Shabaninejad, Ahmad Movahedpour, Farzaneh Fallahi, Mona Taghavipour, Younes Ghasemi, Maryam Akbari, Alimohammad Shafiee, Sarah Hajighadimi, Sanaz Moradizarmehri, Ebrahim Razi, Amir Savardashtaki & Hamed Mirzaei. (2020) Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells. Cell & Bioscience 10:1.
Crossref
Crossref
Zhao-Jun Li, Ya-Jun Hou, Gang-Ping Hao, Xiao-Xuan Pan, Hong-Rong Fei & Feng-Ze Wang. (2020) CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells. Journal of Cell Communication and Signaling 14:4, pages 377-387.
Crossref
Crossref
Jiafeng Wang, Xuefei Zhou, Huifang Wang, Qian Xiao, Kefeng Ding, Xue Dong, Shufeng Xu, Bo Shen, Jihong Sun, Zhuxian Zhou, Jianbin Tang, Xiangrui Liu & Youqing Shen. (2020) Autophagy-inhibiting polymer as an effective nonviral cancer gene therapy vector with inherent apoptosis-sensitizing ability. Biomaterials 255, pages 120156.
Crossref
Crossref
Balak Das Kurmi, Preeti Patel, Rishi Paliwal & Shivani Rai Paliwal. (2020) Molecular approaches for targeted drug delivery towards cancer: A concise review with respect to nanotechnology. Journal of Drug Delivery Science and Technology 57, pages 101682.
Crossref
Crossref
Yuanlin Qi, Lin Qi, Minglian Qiu, Caiyun Yao, Mingfang Zhang, Jianbo Lin, Zhonghua Zheng, Chujia Chen, Hongxiang Li & Shiwei Duan. (2020) Hypermethylation of tumor necrosis factor decoy receptor gene in non‑small lung cancer. Oncology Letters.
Crossref
Crossref
Diego De Miguel, Ana Gallego-Lleyda, Miguel Martinez-Ara, Javier Plou, Alberto Anel & Luis Martinez-Lostao. (2019) Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential. Cancers 11:12, pages 1948.
Crossref
Crossref
Hui-hai Zhong, Hui-yuan Wang, Jian Li & Yong-zhuo Huang. (2019) TRAIL-based gene delivery and therapeutic
strategies. Acta Pharmacologica Sinica 40:11, pages 1373-1385.
Crossref
Crossref
Harish Potu, Malathi Kandarpa, Luke F. Peterson, Nicholas J. Donato & Moshe Talpaz. (2019) Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells. Oncotarget 10:56, pages 5745-5754.
Crossref
Crossref
Adel Naimi, Atefeh Entezari, Majid Farshdousti Hagh, Ali Hassanzadeh, Raedeh Saraei & Saeed Solali. (2018) Quercetin sensitizes human myeloid leukemia KG‐1 cells against TRAIL‐induced apoptosis. Journal of Cellular Physiology 234:8, pages 13233-13241.
Crossref
Crossref
Yang GuoZhenzhen ZhangXiaogang XuZhenyu XuShibing WangDongsheng HuangYifei LiXiaozhou MouFanlong LiuCharlie Xiang. (2019) Menstrual Blood-Derived Stem Cells as Delivery Vehicles for Oncolytic Adenovirus Virotherapy for Colorectal Cancer. Stem Cells and Development 28:13, pages 882-896.
Crossref
Crossref
Shikha Saini, Lakshmi Sripada, Kiara Tulla, Guilin Qiao, Nicholas Kunda, Ajay V Maker & Bellur S Prabhakar. (2019) MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer. Endocrine-Related Cancer 26:6, pages 551-563.
Crossref
Crossref
Stella Bernardi, Rebecca Voltan, Erika Rimondi, Elisabetta Melloni, Daniela Milani, Carlo Cervellati, Donato Gemmati, Claudio Celeghini, Paola Secchiero, Giorgio Zauli & Veronica Tisato. (2019) TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?. Clinical Science 133:10, pages 1145-1166.
Crossref
Crossref
Puyu Shi, Shuo Zhang, Lei Zhu, Guoqing Qian, Hui Ren, Suresh S. Ramalingam, Mingwei Chen & Shi-Yong Sun. (2019) The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAIL-Induced Apoptosis in NSCLC Cells with Activating EGFR Mutations. Translational Oncology 12:5, pages 705-713.
Crossref
Crossref
Ali Hassanzadeh, Adel Naimi, Majid F. Hagh, Raedeh Saraei, Faroogh Marofi & Saeed Solali. (2019) Kaempferol Improves TRAIL-Mediated Apoptosis in Leukemia MOLT-4 Cells by the Inhibition of Anti-apoptotic Proteins and Promotion of Death Receptors Expression. Anti-Cancer Agents in Medicinal Chemistry 19:15, pages 1835-1845.
Crossref
Crossref
Elena Brin, Katherine Wu, Eleanor Dagostino, Mario Meng-Chiang Kuo, Yudou He, Wei-Jong Shia, Li-Chang Chen, Mariusz Stempniak, Richard Hickey, Robert Almassy, Richard Showalter & James Thomson. (2018) TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase. Oncotarget 9:97, pages 36914-36928.
Crossref
Crossref
Julianne D. Twomey, Liqun Zhao, Shen Luo, Qing Xu & Baolin Zhang. (2018) Tubulin couples death receptor 5 to regulate apoptosis. Oncotarget 9:95, pages 36804-36815.
Crossref
Crossref
Raedeh Saraei, Masoud Soleimani, Ali Akbar Movassaghpour Akbari, Majid Farshdousti Hagh, Ali Hassanzadeh & Saeed Solali. (2018) The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia. Biomedicine & Pharmacotherapy 107, pages 1010-1019.
Crossref
Crossref
Guang-Ming Li, Chao-Jie Liang, Dong-Xin Zhang, Li-Jun Zhang, Ji-Xiang Wu & Ying-Chen Xu. (2018) XB130 Knockdown Inhibits the Proliferation, Invasiveness, and Metastasis of Hepatocellular Carcinoma Cells and Sensitizes them to TRAIL-Induced Apoptosis. Chinese Medical Journal 131:19, pages 2320-2331.
Crossref
Crossref
Yan Zhang, Xinyi Tan, Tianyang Ren, Chao Jia, Zaixing Yang & Hong Sun. (2018) Folate-modified carboxymethyl-chitosan/polyethylenimine/bovine serum albumin based complexes for tumor site-specific drug delivery. Carbohydrate Polymers 198, pages 76-85.
Crossref
Crossref
Yunxia YuCaixia ZhuShaolan ZhouShuhong Chi. (2018)
Association Between
C1q
,
TRAIL
, and
Tim-1
Gene Polymorphisms and Systemic Lupus Erythematosus
. Genetic Testing and Molecular Biomarkers 22:9, pages 546-553.
Crossref
Crossref
You-Take Oh, Guoqing Qian, Jiusheng Deng & Shi-Yong Sun. (2018) Monocyte chemotactic protein-induced protein-1 enhances DR5 degradation and negatively regulates DR5 activation-induced apoptosis through its deubiquitinase function. Oncogene 37:25, pages 3415-3425.
Crossref
Crossref
Ana Gallego-Lleyda, Diego De Miguel, Alberto Anel & Luis Martinez-Lostao. (2018) Lipid Nanoparticles Decorated with TNF-Related Aptosis-Inducing Ligand (TRAIL) Are More Cytotoxic than Soluble Recombinant TRAIL in Sarcoma. International Journal of Molecular Sciences 19:5, pages 1449.
Crossref
Crossref
Rong Ke, Kanchan Vishnoi, Navin Viswakarma, Sreevidya Santha, Subhasis Das, Ajay Rana & Basabi Rana. (2018) Involvement of AMP-activated protein kinase and Death Receptor 5 in TRAIL-Berberine-induced apoptosis of cancer cells. Scientific Reports 8:1.
Crossref
Crossref
Zuzana Nahacka, Jan Svadlenka, Martin Peterka, Marie Ksandrova, Simona Benesova, Jiri Neuzil & Ladislav Andera. (2018) TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1865:3, pages 522-531.
Crossref
Crossref
Xin Deng, Wen Zhao, Laijun Song, Wei Ying & Xinbin Guo. (2018) Pro-apoptotic effect of TRAIL-transfected endothelial progenitor cells on glioma cells. Oncology Letters.
Crossref
Crossref
Tzu-Sheng Hsu, Shu-Ting Mo, Ping-Ning Hsu & Ming-Zong Lai. (2018) c-FLIP is a target of the E3 ligase deltex1 in gastric cancer. Cell Death & Disease 9:2.
Crossref
Crossref
Huanling Wu, L. Jeffrey Medeiros & Ken H. Young. (2018) Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances. Blood Reviews 32:1, pages 8-28.
Crossref
Crossref
D.J. Wible & S.B. Bratton. 2018. Comprehensive Toxicology. Comprehensive Toxicology
362
403
.
Chao-Ming Hung, Liang-Chih Liu, Chi-Tang Ho, Ying-Chao Lin & Tzong-Der Way. (2017) Pterostilbene Enhances TRAIL-Induced Apoptosis through the Induction of Death Receptors and Downregulation of Cell Survival Proteins in TRAIL-Resistance Triple Negative Breast Cancer Cells. Journal of Agricultural and Food Chemistry 65:51, pages 11179-11191.
Crossref
Crossref
Olga Vondálová Blanářová, Barbora Šafaříková, Jarmila Herůdková, Martin Krkoška, Silvie Tománková, Zuzana Kahounová, Ladislav Anděra, Jan Bouchal, Gvantsa Kharaishvili, Milan Král, Petr Sova, Alois Kozubík & Alena Hyršlová Vaculová. (2017) Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10. PLOS ONE 12:11, pages e0188584.
Crossref
Crossref
Agathe Dubuisson & Olivier Micheau. (2017) Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy. Antibodies 6:4, pages 16.
Crossref
Crossref
Katherine A Turner & Michael Kalafatis. (2017) The Case Back on the TRAIL: Death Receptors as Markers for rhTRAIL Sensitivity. The Journal of Applied Laboratory Medicine 2:2, pages 176-185.
Crossref
Crossref
Thomas Efferth. (2017) Cancer combination therapies with artemisinin-type drugs. Biochemical Pharmacology 139, pages 56-70.
Crossref
Crossref
Yelyzaveta Shlyakhtina, Valeria Pavet & Hinrich Gronemeyer. (2017) Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells. Cell Death & Disease 8:8, pages e3025-e3025.
Crossref
Crossref
You-Take Oh, Liang Deng, Jiusheng Deng & Shi-Yong Sun. (2017) The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5. Scientific Reports 7:1.
Crossref
Crossref
Dagmara Jaworska & Ewelina Szliszka. (2017) Targeting Apoptotic Activity Against Prostate Cancer Stem Cells. International Journal of Molecular Sciences 18:8, pages 1648.
Crossref
Crossref
Q Wang, Q Chen, L Zhu, M Chen, W Xu, S Panday, Z Wang, A Li, O D Røe, R Chen, S Wang, R Zhang & J Zhou. (2017) JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells. Oncogenesis 6:7, pages e353-e353.
Crossref
Crossref
Kyung-Hwa Kang, Min Ho Han, Jin-Woo Jeong, Cheol Park, Sang-Hyup Lee, Hai Woong Lee, Sang Hoon Hong, Yung Hyun Choi & Su Hyun Hong. (2017) Bufalin sensitizes human bladder carcinoma cells to TRAIL-mediated apoptosis. Oncology Letters 14:1, pages 853-859.
Crossref
Crossref
Andres Forero, Johanna C. Bendell, Prasanna Kumar, Linda Janisch, Michael Rosen, Qiang Wang, Catherine Copigneaux, Madhuri Desai, Giorgio Senaldi & Michael L. Maitland. (2017) First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors. Investigational New Drugs 35:3, pages 298-306.
Crossref
Crossref
Xun Yuan, Dhonghyo Kho, Jing Xu, Ambikai Gajan, Kongming Wu & Gen Sheng Wu. (2017) ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells. Oncotarget 8:13, pages 21626-21638.
Crossref
Crossref
Xu Wu, Shengpeng Wang, Mingxing Li, Anqi Wang, Yangyang Zhou, Peng Li & Yitao Wang. (2017) Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy. Nanoscale 9:37, pages 13879-13904.
Crossref
Crossref
Małgorzata Kłósek, Andrzej Karol Kuropatnicki, Ewelina Szliszka, Ilona Korzonek-Szlacheta & Wojciech Król. 2017. Nutrition and Functional Foods for Healthy Aging. Nutrition and Functional Foods for Healthy Aging
233
244
.
Siddavaram Nagini & Satwinderjeet Kaur. 2017. Proteases in Human Diseases. Proteases in Human Diseases
375
393
.
Sanjeev Banerjee & Shivani B. Paruthy. 2017. Glucosinolates. Glucosinolates
339
379
.
Gila Kazimirsky, Wei Jiang, Shimon Slavin, Amotz Ziv-Av & Chaya Brodie. (2016) Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL. Stem Cell Research & Therapy 7:1.
Crossref
Crossref
Juanjuan Zhu, Qiujing Zhou & Shuhua Tan. (2016) Targeting miRNAs associated with surface expression of death receptors to modulate TRAIL resistance in breast cancer. Cancer Letters 383:2, pages 154-160.
Crossref
Crossref
O. H. Minchenko, D. O. Tsymbal, D. O. Minchenko & О. O. Ratushna. (2016) The role of the TNF receptors and apoptosis inducing ligands in tumor growth. The Ukrainian Biochemical Journal 88:5, pages 18-37.
Crossref
Crossref
Ping Li, Qing Gu & Xuechang Wu. (2016) Fed-batch production of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in soluble form in Escherichia coli and its purification and characterization. Protein Expression and Purification 126, pages 115-121.
Crossref
Crossref
Cong Luo, Lei Miao, Yi Zhao, Sara Musetti, Yuhua Wang, Kai Shi & Leaf Huang. (2016) A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA. Biomaterials 102, pages 239-248.
Crossref
Crossref
Christina L Zuch de Zafra, Avi Ashkenazi, Walter C Darbonne, Melissa Cheu, Klara Totpal, Shirley Ortega, Heather Flores, Mark D Walker, Bruce Kabakoff, Bert L Lum, Barbara J Mounho-Zamora, Scot A Marsters & Noël O Dybdal. (2016) Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey. Cell Death & Disease 7:8, pages e2338-e2338.
Crossref
Crossref
Yu. S. Gavrilova, N. P. Bgatova, A. O. Solov’eva, K. E. Trifonova, A. P. Lykov, Yu. I. Borodin & V. I. Konenkov. (2016) Target cells for lithium in different forms within a heterogeneous hepatocarcinoma-29 population. Cell and Tissue Biology 10:4, pages 284-289.
Crossref
Crossref
Xuefei Zhou, Xiangrui Liu, Bingxiang Zhao, Xin Liu, Dingcheng Zhu, Nasha Qiu, Quan Zhou, Ying Piao, Zhuxian Zhou, Jianbin Tang & Youqing Shen. (2016) Jumping the nuclear envelope barrier: Improving polyplex-mediated gene transfection efficiency by a selective CDK1 inhibitor RO-3306. Journal of Controlled Release 234, pages 90-97.
Crossref
Crossref
Weiqiang Zhou, Xiuyan Feng, Han Han, Shanchun Guo & Guangdi Wang. (2016) Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells. Scientific Reports 6:1.
Crossref
Crossref
Joanna L Fox & Marion MacFarlane. (2016) Targeting cell death signalling in cancer: minimising ‘Collateral damage’. British Journal of Cancer 115:1, pages 5-11.
Crossref
Crossref
Juli R. Bagó, Guillaume J. Pegna, Onyi Okolie, Mahsa Mohiti-Asli, Elizabeth G. Loboa & Shawn D. Hingtgen. (2016) Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma. Biomaterials 90, pages 116-125.
Crossref
Crossref
You-Take Oh, Jiusheng Deng, Ping Yue & Shi-Yong Sun. (2016) Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells. Scientific Reports 6:1.
Crossref
Crossref
Rui Li, Hao Yang, Dianlong Jia, Qianxue Nie, Huawei Cai, Qing Fan, Lin Wan, Lin Li & Xiaofeng Lu. (2016) Fusion to an albumin-binding domain with a high affinity for albumin extends the circulatory half-life and enhances the in vivo antitumor effects of human TRAIL. Journal of Controlled Release 228, pages 96-106.
Crossref
Crossref
Juli R. Bagó, Guillaume J. Pegna, Onyi Okolie & Shawn D. Hingtgen. (2016) Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer. Biomaterials 84, pages 42-53.
Crossref
Crossref
Dibash Das, Leah Persaud, Jordan Dejoie, Mireille Happy, Oliver Brannigan, Dayenny De Jesus & Moira Sauane. (2016) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) activates caspases in human prostate cancer cells through sigma 1 receptor. Biochemical and Biophysical Research Communications 470:2, pages 319-323.
Crossref
Crossref
Sanjeev Banerjee & Shivani B. Paruthy. 2016. Glucosinolates. Glucosinolates
1
41
.
Mohammed Elmallah & Olivier Micheau. (2015) Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL). Marine Drugs 13:11, pages 6884-6909.
Crossref
Crossref